Aeglea BioTherapeutics Investor Presentation Deck slide image

Aeglea BioTherapeutics Investor Presentation Deck

Leadership and BOD Management team Cameron Turtle Scott Burrows Chief Operating Officer Chief Financial Officer Janet Gunzner-Toste SVP, Operations SPYRE APOGEE THERAPEUTICS Heidy King-Jones Chief Legal Officer Andy Spencer Justin LaFountaine SVP, Preclinical R&D VP, Corporate Development FFAIRMOUNT Josh Friedman SVP, Clinical Development bridgebio eidos aegleat a bridgebio company 93 Dragonfly THERAPEUTICS RACAPITAL Russell J. Cox Chairman MERCK abbvie Board of Directors Peter Harwin Board of Directors @abcuro Seagen Hunter C. Smith Ivana Magovčević-Liebisch Alison Lawton Board of Directors Board of Directors Board of Directors Eisai Seagen ADIMAB Tomas Kiselak Board of Directors SANOFI GENZYME 8 TG Therapeutics Michael Henderson Board of Directors PANDION THERAPEUTICS FairJourney Biologics 34
View entire presentation